Related Experiment Video
Updated: May 28, 2025

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase
Published on: April 29, 2010
[SLFN11 inhibition rescues the Fanconi anemia phenotype by stabilizing stalled replication forks]
Yusuke Okamoto1,2, Anfeng Mu2, Minoru Takata2
1Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University.
Abstract:
Fanconi anemia (FA) is a rare hereditary disorder characterized by hypersensitivity to the interstrand crosslinks (ICLs) induced by cisplatin, mitomycin C, or formaldehyde. We found that inhibition of SLFN11, which has been identified as a dominant determinant of responses to various antitumor drugs such as cisplatin, camptothecin, and PARP inhibitors, rescued ICL sensitivity and partially alleviated FA phenotype by stabilizing replication forks. This suggests that SLFN11 intensifies DNA damage sensitivity in FA cells, and could be a novel therapeutic target for the FA phenotype. We also found that human SLFN11 and mouse Slfn8/9 share a functional similarity. In this review, we summarize the interplay between SLFN11 and DNA damage, including functional analysis of SLFN11 and its mouse ortholog.
Insights
Inhibition of SLFN11 protein rescues DNA damage sensitivity in Fanconi anemia (FA) cells by stabilizing replication forks. This finding reveals SLFN11 as a potential therapeutic target for FA treatment.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Context:
- Fanconi anemia (FA) is a rare genetic disorder.
- FA patients exhibit hypersensitivity to DNA interstrand crosslinks (ICLs).
- SLFN11 is a key determinant of drug sensitivity in cancer cells.
Purpose:
- To investigate the role of SLFN11 in FA.
- To explore SLFN11 as a therapeutic target for FA.
Summary:
- SLFN11 inhibition rescued ICL sensitivity in FA cells.
- SLFN11 stabilization of replication forks partially alleviated FA phenotype.
- Human SLFN11 and mouse Slfn8/9 share functional similarity.
Impact:
- SLFN11 intensifies DNA damage sensitivity in FA cells.
- SLFN11 inhibition presents a novel therapeutic strategy for FA.
- Understanding SLFN11-DNA damage interplay informs FA treatment approaches.
Related Concept Videos
Restarting Stalled Replication Forks
The DNA Replication Fork
DNA Damage can Stall the Cell Cycle
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Replicative Cell Senescence
Negative Regulator Molecules

